Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Thanks for responding
View:
Post by YukonJezza on Mar 01, 2021 1:07pm

Thanks for responding

I'm just trying to figure this IP thing out.
Comment by 3burtc on Mar 01, 2021 1:11pm
Alain Wilson bought some share and he has nothing to do with AH. Looks like we have a BIG pharma news printing off the press. Glta.
Comment by Miso420 on Mar 01, 2021 1:38pm
that sounds like a "buy"
Comment by CalgaryATE on Mar 01, 2021 1:48pm
According to SEDI, Antibe Holdings held 15 million shares (1.5 million after the reverse split) from June 2013 - June 2017 (after which point they ceased to be an insider and having to report on SEDI).  According to the last financials, on Dec. 31, 2020 Holdings owned 3.2% of the common shares (of which there were 38,779,772), meaning that Holdings owned about 1.24 million ATE shares.   ...more  
Comment by Pragmatist on Mar 01, 2021 2:22pm
Thay makes sense!  So the recent insider buy was not really a buy at all, but a transfer of ownership from AH to Antibe for the insider shares involved.
Comment by clubhouse19 on Mar 01, 2021 3:08pm
  so I did some research on Antibe Holdings    In Dec of 2009..Antibe therapeutics changed their name to Antibe Holdings Inc 307 1 St E Cochrane Alberta Question remains  as to how they calculated the worth of the shares transfered to Antibe Therapeutics Insiders.  Anyone know why the Intellectual properties were segregated from the company and where was Antibe ...more  
Comment by 3burtc on Mar 01, 2021 3:19pm
I doubt these shares have anything to do with Ah. However all these transactions look rushed, much like the bought deal.
Comment by clubhouse19 on Mar 01, 2021 3:31pm
 Well the vlue of 6.38 per share was on feb 17 the same time the Deal was announced. Would have looked fishy if they would have made the transfer at the low after the sell off that brought it below 5.00 where they would have gotten  at least 20% more shares in Antibe. I think it does have to do with the Tranfer of the tech and the financing.
Comment by Pragmatist on Mar 01, 2021 5:57pm
https://www.lawinsider.com/documents/i2B4LnlNM4X     This quote  was taken from the 2017 Annual Information Form and might answer some of your questions.    "CORPORATE STRUCTURE‌  General  The Company was incorporated under the Business Corporations Act (Ontario) on May 5, 2009. The Company was originally established under the legal name ...more  
Comment by Amigo11 on Mar 01, 2021 4:48pm
Well go onto Canadian Insider and check the trades yourself "acquisition done privately"
Comment by YukonJezza on Mar 01, 2021 9:45pm
thanks for spending the time on this reply. I appreciate it . Yukon
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities